Kristen Hallam on Muck Rack

Kristen Hallam

Verified
Covers:  science, health policy, biotechnology, mergers & acquisitions, health, pharmaceutics
Doesn't Cover: clinical trial initiation, new product launches

@BloombergNews health editor in London. @NorthwesternU alum, @AHCJ member. Email: khallam@bloomberg.net. RTs & links not endorsements.

Shrinking Talent Pool May Bind Biotechs After Brexit

bloomberg.com — The country that produced Dolly the cloned sheep, Viagra and the first IVF baby may find its scientific wings a little clipped when it leaves the European Union. About 1 billion pounds ($1.3 billion) in research funding may drain out of programs that seek to develop new medicines in coming years, according to analysts at Shore Capital Group Ltd.

Anti-Obesity Injection Attracts More Patients Than Pills: Chart

bloomberg.com — An injection that's more popular than a pill? That's the case for Novo Nordisk A/S's Saxenda shot for obesity. While the injection may be less pleasant than taking a pill, it's effective: Saxenda and Vivus Inc.'s Qsymia have the highest odds of achieving at least a 5 percent reduction in weight, according to data published in June.

Medtronic to buy HeartWare for $1.1 billion

bostonglobe.com — Medtronic Plc said it will buy HeartWare International Inc. for about $1.1 billion, gaining technology to treat heart-failure patients. Medtronic will pay $58 a share, almost double HeartWare's Friday closing price of $29.98, the company said Monday in a statement.

Medtronic adds heart devices in $1.1B HeartWare deal

pbn.com — LONDON - Medtronic PLC, the world's biggest maker of heart-rhythm devices, agreed to buy HeartWare International Inc. for about $1.1 billion, paying a premium of 93 percent to gain less-invasive technology for treating advanced heart-failure patients. Medtronic will pay $58 a share, almost double HeartWare's Friday closing price of $29.98, according to a statement Monday.

Medtronic Adds Heart Devices in $1.1 Billion HeartWare Deal

bloomberg.com — Medtronic Plc said it will buy HeartWare International Inc. for about $1.1 billion, gaining technology to treat heart-failure patients. Medtronic will pay $58 a share, almost double HeartWare's Friday closing price of $29.98, the company said Monday in a statement.

Gilde Healthcare Raises $282 Million Fund With Philips, J&J

bloomberg.com — Gilde Healthcare raised 250 million euros ($282 million) for its latest health investment fund, with an increasing focus on digital applications designed to improve treatment and cut costs. The fund's investors include Royal Philips NV, Johnson & Johnson, a Danish government-sponsored fund and the European Investment Fund, Gilde said Tuesday in a statement.

Top News from Kristen Hallam's Friends

Johnson & Johnson to Buy Vogue Hair Care for $3.3 Billion

bloomberg.com — Johnson & Johnson agreed to buy Vogue International, a closely held hair-care company, for about $3.3 billion in cash. The acquisition will include OGX shampoos, conditioners and styling products, as well as the FX line of styling products and the Proganix and Maui Moisture brands, New Brunswick, New Jersey-based J&J said Thursday in a statement.

Mobile phone link to cancer stirred up by rat study findings

livemint.com — The results undercut the notion that radiation from cell phones can't cause cancer, according to government researchers London/Minneapolis/Portland: Preliminary findings from a controversial study in rats is reigniting a long-running debate over whether mobile-phone use can cause cancer.

Mobile-Phone Link To Cancer Stirred Up By Report On Rat Study

ndtv.com — Research in rats is re-igniting the long-running debate over whether mobile-phone use can cause cancer. Two types of tumors -- one in the brain, one in the heart -- were spotted in some male rats exposed to radiofrequency radiation at levels used by the U.S.
More Articles →
Aug 24, 2016

RT @JohnCendpts: More than likely selumetinib, unless that is a complete zero. Soriot hates second-raters as well as underperformers  https://twitter.com/kristen_hallam/status/768395670076153856 

Aug 24, 2016

@JohnCendpts Ooh, what else is on the island of misfit drugs?

Aug 24, 2016

@lisafleisher I actually don't use it on my face. I use AHA or BHA solutions on my face. And moisturize like heck.

Aug 24, 2016

RT @ByJonGardner: .@cardiobrief has more on the missing Cardiorentis/ularitide data. Good work, Larry!  http://ow.ly/Kxst303wTfI 

Aug 24, 2016

Pfizer's busy this week - Pfizer to buy antibiotics business from AstraZeneca  http://bloom.bg/2c5mway  via @business $PFE $AZN


Are You a Journalist?

Create a free Muck Rack account to customize your profile and upload a portfolio of your best work.

Create a Portfolio